BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38853212)

  • 1. The value of apparent diffusion coefficient values in predicting Gleason grading of low to intermediate-risk prostate cancer.
    Yan X; Ma K; Zhu L; Pan Y; Wang Y; Shi J; Mai X
    Insights Imaging; 2024 Jun; 15(1):137. PubMed ID: 38853212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
    Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
    Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
    BJU Int; 2017 Jan; 119(1):57-66. PubMed ID: 26823024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score.
    Donati OF; Afaq A; Vargas HA; Mazaheri Y; Zheng J; Moskowitz CS; Hricak H; Akin O
    Clin Cancer Res; 2014 Jul; 20(14):3705-11. PubMed ID: 24850842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of multiparametric MRI parameters for Gleason score and cellularity metrics of prostate cancer in different zones: a quantitative comparison.
    Gao J; Zhang Q; Zhang C; Chen M; Li D; Fu Y; Lv X; Zhang B; Guo H
    Clin Radiol; 2019 Nov; 74(11):895.e17-895.e26. PubMed ID: 31337490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of relationships between the final Gleason score, PI-RADS v2 score, ADC value, PSA level, and tumor diameter in patients that underwent radical prostatectomy due to prostate cancer.
    Gündoğdu E; Emekli E; Kebapçı M
    Radiol Med; 2020 Sep; 125(9):827-837. PubMed ID: 32266690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
    Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
    Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
    Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
    Li X; Wang H; Gao J; Jiang L; Chen M
    Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma.
    Yao R; Cheng A; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):322-328. PubMed ID: 36957971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Benefit of Apparent Diffusion Coefficient in Evaluating the Invasiveness of Hepatocellular Carcinoma.
    Jing M; Cao Y; Zhang P; Zhang B; Lin X; Deng L; Han T; Zhou J
    Front Oncol; 2021; 11():719480. PubMed ID: 34504795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
    Wu CJ; Zhang YD; Bao ML; Li H; Wang XN; Liu XS; Shi HB
    AJR Am J Roentgenol; 2017 Nov; 209(5):1081-1087. PubMed ID: 28834443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters.
    Surov A; Gottschling S; Mawrin C; Prell J; Spielmann RP; Wienke A; Fiedler E
    Transl Oncol; 2015 Dec; 8(6):517-23. PubMed ID: 26692534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.
    Chinnappan S; Chandra P; Kumar JS; Chandran G; Nath S
    Indian J Nucl Med; 2021; 36(4):377-384. PubMed ID: 35125755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
    Yan B; Zhao T; Liang X; Niu C; Ding C
    Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Effect of MRI Diffusion-weighted Imaging Apparent Diffusion Coefficient Value on Postoperative Recurrence of Brain Glioma.
    Liu D; Liu W
    Altern Ther Health Med; 2023 Oct; ():. PubMed ID: 37883754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.